Skip to main content
Hauptrubriken
CME Facharzt-Training Webinare Zeitschriften Bücher e.Medpedia Podcast
Service
Jobbörse Info & Hilfe
Fachgebiete
Anästhesiologie Allgemeinmedizin Arbeitsmedizin Augenheilkunde Chirurgie Dermatologie Gynäkologie und Geburtshilfe HNO Innere Medizin Kardiologie Neurologie Onkologie und Hämatologie Orthopädie und Unfallchirurgie Pädiatrie Pathologie Psychiatrie Radiologie Rechtsmedizin Urologie Zahnmedizin
Themen
Klimawandel und Gesundheit Neues aus dem Markt COVID-19 Praxis und Beruf Seltene Erkrankungen GOÄ & EBM Panorama
Sammlungen
Kasuistiken Algorithmen & Infografiken Blickdiagnosen Arthropedia FlapFinder (für Dermatochirurgen) Videos Kongressberichterstattung Medizin für Apothekerinnen und Apotheker Für Ärztinnen und Ärzte in Weiterbildung Für Medizinstudierende

Live-Webinar: Aktuelle Leitlinien bei Herz-Kreislauf-Erkrankungen

Konkret geht es um den Diabetes-Patienten mit kardiovaskulären Erkrankungen oder Risiken, die Herzinsuffizienz sowie die kardiovaskuläre Primär- und Sekundärprävention. Sind Sie hier schon auf dem neuesten Stand? Unsere Experten beleuchten, wo und warum das bisherige Procedere geändert werden soll und was in der Praxis sinnvoll ist. Holen Sie sich Ihr Update und 2 CME-Punkte beim MMW-Webinar am 24. April von 17.30 bis 19 Uhr. 
Erweiterte Suche
Anmelden
nach oben
Infection
Erschienen in: Infection 4/2016

06.11.2015 | Review

Trichomonas vaginalis: pathogenicity and potential role in human reproductive failure

verfasst von: Ewelina Mielczarek, Joanna Blaszkowska

Erschienen in: Infection | Ausgabe 4/2016

Einloggen, um Zugang zu erhalten

Abstract

Purpose

Trichomonas vaginalis, which colonizes the genitourinary tract of men and women, is a sexually transmitted parasite causing symptomatic or asymptomatic trichomoniasis. The host–parasite relationship is very complex, and clinical symptoms cannot likely be attributed to a single pathogenic effect. Among the many factors responsible for interactions between T. vaginalis and host tissues, contact-dependent and contact-independent mechanisms are important in pathogenicity, as is the immune response.

Methods

This review focuses on the potential virulence properties of T. vaginalis and its role in female and male infertility.

Results

It highlights the association between T. vaginalis infection and serious adverse health consequences experienced by women, including infertility, preterm birth and low-birth-weight infants. Long-term clinical observations and results of in vitro experimental studies indicate that in men, trichomoniasis has been also associated with infertility through inflammatory damage to the genitourinary tract or interference with sperm function.

Conclusion

These results contribute significantly to improving our knowledge of the role of parasitic virulence factors in the development of infection and its role in human infertility.
Literatur
1.
2.
3.
4.
5.
Secor WE, Meites E, Starr MC, Workowski KA. Neglected parasitic infections in the United States: trichomoniasis. Am J Trop Med Hyg. 2014;90:800–4.CrossRefPubMedPubMedCentral
6.
Silver BJ, Guy RJ, Kaldor JM, Jamil MS, Rumbold AR. Trichomonas vaginalis as a cause of perinatal morbidity: a systematic review and meta-analysis. Sex Transm Dis. 2014;41:369–76.CrossRefPubMed
7.
Simhan HN, Anderson BL, Krohn MA, Heine RP, Martinez de Tejada B, Landers DV, Hillier SL. Host immune consequences of asymptomatic Trichomonas vaginalis infection in pregnancy. Am J Obstet Gynecol. 2007;196:59.e1-5.CrossRefPubMed
8.
9.
McClelland RS, Sangare L, Hassan WM, Lavreys L, Mandaliya K, Kiarie J, Ndinya-Achola J, Jaoko W, Baeten JM. Infection with Trichomonas vaginalis increases the risk of HIV-1 acquisition. J Infect Dis. 2007;195:698–702.CrossRefPubMed
10.
Stark JR, Judson G, Alderete JF, Mundodi V, Kucknoor AS, Giovannucci EL, Platz EA, Sutcliffe S, Fall K, Kurth T, Ma J, Stampfer MJ, Mucci LA. Prospective study of Trichomonas vaginalis infection and prostate cancer incidence and mortality: physicians’ health study. J Natl Cancer Inst. 2009;101:1406–11.CrossRefPubMedPubMedCentral
11.
Afzan MY, Suresh K. Pseudocyst forms of Trichomonas vaginalis from cervical neoplasia. Parasitol Res. 2012;111:371–81.CrossRefPubMed
12.
Chapin K, Sndrea S. APTIMA Trichomonas vaginalis, a transcription-mediated amplification assay for detection of Trichomonas vaginalis in urogenital specimens. Expert Rev Mol Diagn. 2011;11:679–88.CrossRefPubMed
13.
14.
Midlej V, Benchimol M. Trichomonas vaginalis kills and eats-evidence for phagocytic activity as a cytopathic effect. Parasitology. 2010;137:65–76.CrossRefPubMed
15.
Pereira-Neves A, Benchimol M. Phagocytosis by Trichomonas vaginalis: new insights. Biol Cell. 2007;99:87–101.CrossRefPubMed
16.
Benchimol M, de Andrade Rosa I, da Silva Fontes R, Burla Dias AJ. Trichomonas adhere and phagocytose sperm cells: adhesion seems to be a prominent stage during interaction. Parasitol Res. 2008;102:597–604.CrossRefPubMed
17.
de Miguel N, Lustig G, Twu O, Chattopadhyay A, Wohlschlegel JA, Johnson PJ. Proteome analysis of the surface of Trichomonas vaginalis reveals novel proteins and strain-dependent differential expression. Mol Cell Proteomics. 2010;9:1554–66.CrossRefPubMedPubMedCentral
18.
Hirt RP, de Miguel N, Nakjang S, Dessi D, Liu YC, Diaz N, Rappelli P, Acosta-Serrano A, Fiori PL, Mottram JC. Trichomonas vaginalis pathobiology new insights from the genome sequence. Adv Parasitol. 2011;77:87–140.CrossRefPubMed
19.
Pereira-Neves A, Benchimol M. Trichomonas vaginalis: in vitro survival in swimming pool water samples. Exp Parasitol. 2008;118:438–41.CrossRefPubMed
20.
Petrin D, Delgaty K, Bhatt R, Garber G. Clinical and microbiological aspects of Trichomonas vaginalis. Clin Microbiol Rev. 1998;11:300–17.PubMedPubMedCentral
21.
Pereira-Neves A, Riberio KC, Benchimol M. Pseudocysts in trichomonads—new insights. Protist. 2003;154:313–29.CrossRefPubMed
22.
Hussein EM, Atwa MM. Infectivity of Trichomonas vaginalis pseudocysts inoculated intra-vaginally in mice. J Egypt Soc Parasitol. 2008;38:749–62.PubMed
23.
Shafir SC, Sorvillo FJ, Smith L. Current issues and considerations regarding trichomoniasis and human immunodeficiency virus in African-Americans. Clin Micobiol Rev. 2009;22:37–45.CrossRef
24.
Seña AC, Miller WC, Hobbs MM, Schwebke JR, Leone PA, Swygard H, Atashili J, Cohen MS. Trichomonas vaginalis infection in male sexual partners: implications for diagnosis, treatment, and prevention. Clin Infect Dis. 2007;44:13–22.CrossRefPubMed
25.
Sherman JK, Hostetle TL, McHenry K, Daly JJ. Cryosurvival of Trichomonas vaginalis during cryopreservation of human semen. Cryobiology. 1991;28:246–50.CrossRefPubMed
26.
Habib FS, Metwally DM, Habib KS. Cryopreservation of Trichomonas vaginalis: a trial of using four different cryoprotectants. J Egypt Soc Parasitol. 2004;34:931–40.PubMed
27.
28.
Schwandt A, William C, Beig RH. Perinatal transmission of Trichomonas vaginalis: a case report. J Reprod Med. 2008;53:59–61.PubMed
29.
Charles SX. Epidemiology of Trichomonas vaginalis (TV) in rural adolescent and juvenile children. J Trop Pediatr. 1991;37:90.CrossRefPubMed
30.
31.
Peterson K, Drame D. Iatrogenic transmission of Trichomonas vaginalis by a traditional healer. Sex Transm Infect. 2010;86:353–4.CrossRefPubMed
32.
Crucitti T, Jespers V, Mulenga C, Khondowe S, Vandepitte J, Buvé A. Non-sexual transmission of Trichomonas vaginalis in adolescent girls attending school in Ndola, Zambia. PLoS ONE. 2011;6:e16310.CrossRefPubMedPubMedCentral
33.
Ryan CM, de Migue N, Johnson PJ. Trichomonas vaginalis: current understanding of host–parasite interactions. Essays Biochem. 2011;51:161–75.CrossRefPubMed
34.
Lin WC, Chang WT, Chang TY, Shin JW. The pathogenesis of human cervical epithelium cells induced by interacting with Trichomonas vaginalis. PLoS ONE. 2015;10:e0124087.CrossRefPubMedPubMedCentral
35.
36.
Figueroa-Angulo EE, Rendón-Gandarilla FJ, Puente-Rivera J, Calla-Choque JS, Cárdenas-Guerra RE, Ortega-López J, Quintas-Granados LI, Alvarez-Sánchez ME, Arroyo R. The effects of environmental factors on the virulence of Trichomonas vaginalis. Microbes Infect. 2012;14:1411–27.CrossRefPubMed
37.
Kusdian G, Woehle C, Martin WF, Gould SB. The actin-based machinery of Trichomonas vaginalis mediates flagellate-amoeboid transition and migration across host tissue. Cell Microbiol. 2013;15:1707–21.PubMed
38.
39.
Pindak FF, Mora de Pindak M, Jr Gardner WA. Contact-independent cytotoxicity of Trichomonas vaginalis. Genitourin Med. 1993;69:35–40.PubMedPubMedCentral
40.
41.
Jiang I, Tsai CK, Chen SC, Wang SH, Amiraslanov I, Chang CF, Wu WJ, Tai JH, Liaw YC, Huang TH. Molecular basis of the recognition of the ap65-1 gene transcription promoter elements by a Myb protein from the protozoan parasite Trichomonas vaginalis. Nucl Acids Res. 2011;39:8992–9008.CrossRefPubMedPubMedCentral
42.
Twu O, de Miguel N, Lustig G, Stevens GC, Vashisht AA, Wohlschlegel JA, Johnson PJ. Trichomonas vaginalis exosomes deliver cargo to host cells and mediate host:parasite interactions. PLoS Pathog. 2013;9:e1003482.CrossRefPubMedPubMedCentral
43.
Min DY, Hyun KH, Ryu JS, Ahn MH, Cho MH. Degradations of human immunoglobulins and hemoglobin by a 60 kDa cysteine proteinase of Trichomonas vaginalis. Korean J Parasitol. 1998;36:261–8.CrossRefPubMedPubMedCentral
44.
Lubick KJ, Burgess DE. Purification and analysis of a phospholipase A2-like lytic factor of Trichomonas vaginalis. Infect Immun. 2004;72:1284–90.CrossRefPubMedPubMedCentral
45.
Yadav M, Gupta I, Malla N. Kinetics of immunoglobulin G, M, A and IgG subclass responses in experimental intravaginal trichomoniasis: prominence of IgG1 response. Parasite Immunol. 2005;27:461–7.CrossRefPubMed
46.
Reighard SD, Sweet RL, Vicetti MC, Vicetti MRD, Chivukula M, Krishnamurti U, Cherpes TL. Endometrial leukocyte subpopulations associated with Chlamydia trachomatis, Neisseria gonorrhoeae, and Trichomonas vaginalis genital tract infection. Am J Obstet Gynecol. 2011;205:324.CrossRefPubMedPubMedCentral
47.
Ibáñez-Escribano A, Nogal-Ruiz JJ, Pérez-Serrano J, Gómez-Barrio A, Escario JA, Alderete JF. Sequestration of host-CD59 as potential immune evasion strategy of Trichomonas vaginalis. Acta Trop. 2015;149:1–7.CrossRefPubMed
48.
Provenzano D, Alderete JF. Analysis of human immunoglobulin-degrading cysteine proteinases of Trichomonas vaginalis. Infect Immun. 1995;63:3388–95.PubMedPubMedCentral
49.
Parent KN, Takagi Y, Cardone G, Olson NH, Ericsson M, Yang M, Lee Y, Asara JM, Fichorova RN, Baker TS, Nibert ML. Structure of a protozoan virus from the human genitourinary parasite Trichomonas vaginalis. MBio. 2013;4:e00056-13.CrossRefPubMedPubMedCentral
50.
Conrad MD, Gorman AW, Schillinger JA, Fiori PL, Arroyo R, Malla N, Dubey ML, Gonzalez J, Blank S, Secor WE, Carlton JM. Extensive genetic diversity, unique population structure and evidence of genetic exchange in the sexually transmitted parasite Trichomonas vaginalis. PLoS Negl Trop Dis. 2012;6(3):e1573.CrossRefPubMedPubMedCentral
51.
Malla N, Kaul P, Sehgal R, Gupta I. The presence of dsRNA virus in Trichomonas vaginalis isolates from symptomatic and asymptomatic Indian women and its correlation with in vitro metronidazole sensitivity. Indian J Med Microbiol. 2011;29:152–7.CrossRefPubMed
52.
La Vignera S, Vicari E, Condorelli RA, D’Agata R, Calogero AE. Male accessory gland infection and sperm parameters (review). Int J Androl. 2011;34:e330–47.CrossRefPubMed
53.
Gardner WA Jr, Culberson DE, Bennett BD. Trichomonas vaginalis in the prostate gland. Arch Pathol Lab Med. 1986;110:430–2.PubMed
54.
Mitteregger D, Aberle SW, Makristathis A, Walochnik J, Brozek W, Marberger M, Kramer G. High detection rate of Trichomonas vaginalis in benign hyperplastic prostatic tissue. Med Microbiol Immunol. 2012;201:113–6.CrossRefPubMed
55.
Sutcliffe S, Neace C, Magnuson NS, Reeves R, Alderete JF. Trichomonosis, a common curable STI, and prostate carcinogenesis—a proposed molecular mechanism. PLoS Pathog. 2012;8:e1002801.CrossRefPubMedPubMedCentral
56.
Martinez-Garcia F, Regadera J, Mayer R, Sanchez S, Nistal M. Protozoan infections in the male genital tract. J Urol. 1996;156:340–9.CrossRefPubMed
57.
Mali NM, Hazari KT, Meherji PK. Interaction between T. vaginalis and human spermatozoa in the genital tract: Papanicolaou-stained cervical smear findings. Acta Cytol. 2006;50:357–8.PubMed
58.
Gopalkrishnan K, Hinduja IN, Kumar TC. Semen characteristics of asymptomatic males affected by Trichomonas vaginalis. J In Vitro Fert Embryo Transf. 1990;7:165–7.CrossRefPubMed
59.
Tuttle JP, Holbrook TW, Derrick FC. Interference of human spermatozoal motility by Trichomonas vaginalis. J Urol. 1977;118:1024–5.PubMed
60.
Roh J, Lim YS, Seo MY, Choi Y, Ryu JS. The secretory products of Trichomonas vaginalis decrease fertilizing capacity of mice sperm in vitro. Asian J Androl. 2015;17:319–23.CrossRefPubMed
61.
Gimenes F, Souza RP, Bento JC, Teixeira JJV, Maria-Engler SS, Bonini MG, Consolaro MEL. Male infertility: a public health issue caused by sexually transmitted pathogen. Nat Rev Urol. 2014;11:672–7.CrossRefPubMed
62.
Lucena E, Moreno-Ortiz H, Coral L, Lombana O, Moran A, Esteban-Pérez CI. Unexplained infertility caused by a latent but serious intruder: Trichomonas vaginalis? JFIV Reprod Med Genet. 2015;3:139. doi:10.​4172/​2375-4508.​1000139.
63.
Lloyd G, Case JR, De Frias D, Brannigan RE. Trichomonas vaginalis orchitis with associated severe oligoasthenoteratospermia and hypogonadism. J Urol. 2003;170:924–5.CrossRefPubMed
64.
Janssenswillen C, Tournaye H, Pierard D, Devroey P, Van Steirteghem A. Microsurgical epididymal sperm aspiration with motile trophozoite cells but no spermatozoa. Hum Reprod. 1997;12:2217–9.CrossRefPubMed
65.
66.
Hobbs MM, Kazembe P, Reed AW, Miller WC, Nkata E, Zimba D, Daly CC, Chakraborty H, Cohen MS, Hoffman I. Trichomonas vaginalis as a cause of urethritis in Malawian men. Sex Transm Dis. 1999;26:381–7.CrossRefPubMed
67.
Yap EH, Ho TH, Chan YC, Thong TW, Ng GC, Ho LC, Singh M. Serum antibodies to Trichomonas vaginalis in invasive cervical cancer patients. Genitourin Med. 1995;71:402–4.PubMedPubMedCentral
68.
Viikki M, Pukkala E, Nieminen P, Hakama M. Gynaecological infections as risk determinants of subsequent cervical neoplasia. Acta Oncol. 2000;39:71–5.CrossRefPubMed
69.
Lazenby GB, Taylor PT, Badman BS, McHaki E, Korte JE, Soper DE, Young Pierce J. An association between Trichomonas vaginalis and high-risk human papillomavirus in rural Tanzanian women undergoing cervical cancer screening. Clin Ther. 2014;36:38–45.CrossRefPubMed
70.
Pustan L, Ailiesei O, Dunca S. Trichomonas vaginalis—a risk factor for cervical cancer. Gen Mol Biol. 2010;11:107–12.
71.
Chigbu LN, Aluka C, Eke RA. Trichomoniasis as an indicator for existing sexually transmitted infections in women in Aba, Nigeria. Ann Afr Med. 2006;5:1–5.
72.
Coleman JS, Gaydos CA, Witter F. Trichomonas vaginalis vaginitis in obstetrics and gynecology practice: new concepts and controversies. Obstet Gynecol Surv. 2013;68:43–50.CrossRefPubMedPubMedCentral
73.
Guenthner PC, Secor WE, Dezzutti CS. Trichomonas vaginalis—induced epithelial monolayer disruption and human immunodeficiency virus type 1 (HIV-1) replication: implications for the sexual transmission of HIV-1. Infect Immun. 2005;73:4155–60.CrossRefPubMedPubMedCentral
74.
El-Shazly AM, El-Naggar HM, Soliman M, El-Negeri M, El-Nemr HE, Handousa AE, Morsy TA. A study on trichomoniasis vaginalis and female infertility. J Egypt Soc Parasitol. 2001;31:545–53.PubMed
75.
El-Sharkawy IM, Hamza SM, El-Sayed MK, El-Negeri M, El-Nemr HE, Handousa AE, Morsy TA. Correlation between trichomoniasis vaginalis and female infertility. J Egypt Soc Parasitol. 2000;30:287–94.PubMed
76.
Ness RB, Kip KE, Hillier SL, Soper DE, Stamm CA, Sweet RL, Rice P, Richter HE. A cluster analysis of bacterial vaginosis-associated microflora and pelvic inflammatory disease. Am J Epidemiol. 2005;162:585–90.CrossRefPubMed
77.
Moodley P, Wilkinson D, Connolly C, Moodley J, Sturm AW. Trichomonas vaginalis is associated with pelvic inflammatory disease in women infected with human immunodeficiency virus. Clin Infect Dis. 2002;34:519–22.CrossRefPubMed
78.
Cherpes TL, Wiesenfeld HC, Melan MA, Kant JA, Cosentino LA, Meyn LA, Hillier SL. The associations between pelvic inflammatory disease, Trichomonas vaginalis infection, and positive herpes simplex virus type 2 serology. Sex Transm Dis. 2006;33:747–52.CrossRefPubMed
79.
Hammond TL, Hankins GD, Snyder RR. Transvaginal-peritoneal migration of Trichomonas vaginalis as a cause of ascites: a report of two cases. J Reprod Med. 1990;35:179–81.PubMed
80.
Simhan HN, Caritis SN, Krohn MA, Hillier SL. The vaginal inflammatory milieu and the risk of early premature preterm rupture of membranes. Am J Obstet Gynecol. 2005;192:213–8.CrossRefPubMed
81.
Smith LM, Wang M, Zangwill K, Yeh S. Trichomonas vaginalis infection in a premature newborn. J Perinatol. 2002;22:502–3.CrossRefPubMed
82.
Cram LF, Zapata MI, Toy EC, Baker B. Genitourinary infections and their association with preterm labor. Am Fam Physician. 2002;65:241–8.PubMed
83.
Cotch MF, Pastorek JG II, Nugent RP, Hillier SL, Gibbs RS, Martin DH, Eschenbach DA, Edelman R, Carey JC, Regan JA, Krohn MA, Klebanoff MA, Rao AV, Rhoads GG. Trichomonas vaginalis associated with low birth weight and preterm delivery. The vaginal infections and prematurity study group. Sex Transm Dis. 1997;24:353–60.CrossRefPubMed
84.
Trintis J, Epie N, Boss R, Riedel S. Neonatal Trichomonas vaginalis infection: a case report and review of literature. Int J STD AIDS. 2010;21:606–7.CrossRefPubMed
85.
Rasti S, Behrashi M, Mousavi G, Moniri R. Complications of trichomoniasis on the pregnant women. Jundishapur J Microbiol. 2011;4:61–3.
86.
Mann JR, McDermott S, Zhou L, Barnes TL, Hardin J. Treatment of trichomoniasis in pregnancy and preterm birth: an observational study. J Womens Health (Larchmt). 2009;18:493–7.CrossRef
87.
Bruins MJ, van Straaten IL, Ruijs GJ. Respiratory disease and Trichomonas vaginalis in premature newborn twins. Pediatr Infect Dis J. 2013;32:1029–30.CrossRefPubMed
88.
Temesvari P, Kerekes A, Tege A, Szarka K. Demonstration of Trichomonas vaginalis in tracheal aspirates in infants with early respiratory failure. J Matern Fetal Neonatal Med. 2002;11:347–9.CrossRefPubMed
89.
Carter JE, Whithaus KC. Neonatal respiratory tract involvement by Trichomonas vaginalis: a case report and review of the literature. Am J Trop Med Hyg. 2008;78:17–9.PubMed
90.
al-Salihi F L, Curran J P, Wang J. Neonatal Trichomonas vaginalis: report of three cases and review of the literature. Pediatrics 1974;53:196–200.
91.
Azargoon A, Darvishzadeh S. Association of bacterial vaginosis, Trichomonas vaginalis, and vaginal acidity with outcome of pregnancy. Arch Iran Med. 2006;9:213–7.PubMed
92.
Jenny C, Crawford-Jakubiak JE. Committee on child abuse and neglect, American Academy of Pediatrics. The evaluation of children in the primary care setting when sexual abuse is suspected. Pediatrics. 2013;132:e558–67. doi:10.​1542/​peds.​2013-1741.CrossRefPubMed
93.
94.
Kingston MA, Carlin EM, Bansal D. ‘Shelf life’ of Trichomonas vaginalis. Int J STD AIDS. 2003;14:28–9.CrossRefPubMed
95.
Patil MJ, Nagamoti JM, Metgud SC. Diagnosis of Trichomonas vaginalis from vaginal specimens by wet mount microscopy, In Pouch TV culture system, and PCR. J Glob Infect Dis. 2012;4:22–5.CrossRefPubMedPubMedCentral
96.
Nye MB, Schwebke JR, Body BA. Comparison of APTIMA Trichomonas vaginalis transcription-mediated amplification to wet mount microscopy, culture, and polymerase chain reaction for diagnosis of trichomoniasis in men and women. Am J Obstet Gynecol. 2009;200:188.e1-7. doi:10.​1016/​j.​ajog.​2008.​10.​005.CrossRefPubMed
97.
Workowski KA, Bolan GA, Centers for Disease Control and Prevention. Sexually transmitted diseases treatment guidelines, 2015. MMWR Recomm Rep. 2015;5:1–137.
98.
Sherrard J, Ison C, Moody J, Wainwright E, Wilson J, Sullivan A. United Kingdom National Guideline on the Management of Trichomonas vaginalis 2014. Int J STD AIDS. 2014;25:541–9.CrossRefPubMed
Metadaten
Titel
Trichomonas vaginalis: pathogenicity and potential role in human reproductive failure
verfasst von
Ewelina Mielczarek
Joanna Blaszkowska
Publikationsdatum
06.11.2015
Verlag
Springer Berlin Heidelberg
Erschienen in
Infection / Ausgabe 4/2016
Print ISSN: 0300-8126
Elektronische ISSN: 1439-0973
DOI
https://doi.org/10.1007/s15010-015-0860-0

Weitere Artikel der Ausgabe 4/2016

Infection 4/2016 Zur Ausgabe

Original Paper

Gaseous nitric oxide to treat antibiotic resistant bacterial and fungal lung infections in patients with cystic fibrosis: a phase I clinical study

Images in Infection

Polymicrobial soft tissue infection including Shewanella putrefaciens

Case Report

Fever of unknown origin (FUO) in a renal transplant recipient due to drug fever from sirolimus

Case Report

An unexpected cause for cavitary pneumonia and empyema

Case Report

Actinobaculum schaalii, a new cause of knee prosthetic joint infection in elderly

Original Paper

Reasons for not starting antiretroviral therapy in HIV-1-infected individuals: a changing landscape

Leitlinien kompakt für die Innere Medizin

Mit medbee Pocketcards sicher entscheiden.

Seit 2022 gehört die medbee GmbH zum Springer Medizin Verlag

Kostenlos registrieren

Neu im Fachgebiet Innere Medizin

23.04.2024 | Medikamente in Schwangerschaft und Stillzeit | Nachrichten

ICI-Therapie in der Schwangerschaft wird gut toleriert

22.04.2024 | DGIM 2024 | Kongressbericht | Nachrichten

Krebspatienten impfen: Was? Wen? Und wann nicht?

22.04.2024 | DGIM 2024 | Kongressbericht | Nachrichten

Nierenultraschall: Tipps vom Profi

22.04.2024 | DGIM 2024 | Kongressbericht | Nachrichten

Bei RSV-Impfung vor 60. Lebensjahr über Off-Label-Gebrauch aufklären!
weitere anzeigen

Update Innere Medizin

Bestellen Sie unseren Fach-Newsletter und bleiben Sie gut informiert.

Newsletter bestellen
Bildnachweise